Thermo Fisher Scientific Inc


Want a discount? Become a member by purchasing Annual Subscription!
SKU: TMO-2 Category:


Thermo Fisher delivered yet another decent quarter re-emphasizing the effectiveness of their growth strategy, powered by their PPI business system. The company achieved 17% organic growth for the full year of 2021, with 14% organic base business growth and $9.2 billion in COVID-19 response revenue. Throughout the year, Thermo Fisher experienced strong growth in a number of areas, including biosciences, electron microscopy, and its research and safety market channel. Additionally, they launched the Thermo Scientific Orbitrap Exploris MX, a mass detector that provides high-throughput analysis to improve biopharmaceutical development and production, in the fourth quarter. It continues to be a market leader in life sciences and its market share growth trajectory remains upwards. Overall, we are optimistic about Thermo Fisher’s future growth and give it an ‘Outperform’ rating with a revised target price.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!